Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.62 |
| ▸ | NAAA | Q02083 | 1/20 | 0.56 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 4/20 | 0.50 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.50 |
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | RAD52 | P43351 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | CA9 | Q16790 | 1/20 | 0.46 |
| ▸ | FAAH | O00519 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | ACHE | P22303 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1839333 | 0.98 | NAAA (0.59) | ALDH1A1NAAAEPHX1TSHRHCAR2 | |
| SCHEMBL720242 | 0.98 | NAAA (0.59) | ALDH1A1NAAAEPHX1TSHRHCAR2 | |
| SCHEMBL1840756 | 0.98 | NAAA (0.59) | ALDH1A1NAAAEPHX1TSHRHCAR2 | |
| SCHEMBL1836015 | 0.98 | NAAA (0.59) | ALDH1A1NAAAEPHX1TSHRHCAR2 | |
| SCHEMBL1837624 | 0.98 | NAAA (0.59) | ALDH1A1NAAAEPHX1TSHRHCAR2 | |
| SCHEMBL1836973 | 0.98 | NAAA (0.59) | ALDH1A1NAAAEPHX1TSHRHCAR2 | |
| SCHEMBL1837793 | 0.98 | NAAA (0.59) | ALDH1A1NAAAEPHX1TSHRHCAR2 | |
| SCHEMBL448327 | 0.98 | NAAA (0.59) | ALDH1A1NAAAEPHX1TSHRHCAR2 | |
| SCHEMBL1835018 | 0.98 | NAAA (0.59) | ALDH1A1NAAAEPHX1TSHRHCAR2 | |
| SCHEMBL1836808 | 0.98 | NAAA (0.59) | ALDH1A1NAAAEPHX1TSHRHCAR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 445 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4322277-A1 | NON-AQUEOUS ELECTROLYTE, SECONDARY BATTERY, BATTERY MODULE, BATTERY PACK, AND ELECTRICAL DEVICE | Contemporary Amperex Technology Co., Limited (CN) | 2024-02-14 | — | — | EP | claimed |
| EP-2459511-B1 | PROCESS FOR PRODUCING DIPHENYL CARBONATE | SHELL INT RESEARCH (NL) | 2016-04-27 | — | — | EP | claimed |
| US-8569534-B2 | Process for producing diphenyl carbonate | SHELL OIL COMPANY (US) | 2013-10-29 | — | — | US | claimed |
| US-20120190878-A1 | PROCESS FOR PRODUCING DIPHENYL CARBONATE | SHELL OIL COMPANY (US) | 2012-07-26 | — | — | US | claimed |
| EP-2459511-A2 | PROCESS FOR PRODUCING DIPHENYL CARBONATE | SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) | 2012-06-06 | — | — | EP | claimed |
| US-8110698-B2 | Process for producing diphenyl carbonate | SHELL OIL COMPANY (US) | 2012-02-07 | — | — | US | claimed |
| WO-2011014374-A2 | PROCESS FOR PRODUCING DIPHENYL CARBONATE | CATALYTIC DISTILLATION TECHNOLOGIES (US) | 2011-02-03 | — | — | WO | claimed |
| US-20100197952-A1 | PROCESS FOR PRODUCING DIPHENYL CARBONATE | CATALYTIC DISTILLATION TECHNOLOGIES (US) | 2010-08-05 | — | — | US | claimed |
| US-20080161394-A1 | Cosmetic composition comprising at least one volatile carbonic acid ester | L'OREAL S.A. (FR) | 2008-07-03 | — | — | US | claimed |
| WO-2004046153-A1 | PRODRUG ESTERS OF CEFTRIAXONE | RANBAXY LABORATORIES LIMITED (IN) | 2004-06-03 | — | — | WO | claimed |
| US-20260085218-A1 | SEALANT RESIN COMPOSITION, AND USE THEREOF | MITSUI CHEMICALS, INC. (JP) | 2026-03-26 | — | — | US | disclosed |
| EP-4585663-A1 | SEALANT RESIN COMPOSITION AND USE OF SAME | Mitsui Chemicals, Inc. (JP) | 2025-07-16 | — | — | EP | disclosed |
| EP-3306732-B1 | NONAQUEOUS ELECTROLYTE SOLUTION FOR BATTERIES AND LITHIUM SECONDARY BATTERY | MITSUI CHEMICALS INC (JP) | 2025-06-25 | — | — | EP | disclosed |
| US-12255288-B2 | Nonaqueous electrolytic solution for battery and lithium secondary battery | MITSUI CHEMICALS, INC. (JP) | 2025-03-18 | — | — | US | disclosed |
| EP-4519257-A1 | PROCESS FOR THE PREPARATION OF PYROXASULFONE | Adama Agan Ltd. (IL) | 2025-03-12 | — | — | EP | disclosed |
| EP-0072710-B1 | CARBAPENEM DERIVATIVES, THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM | SANKYO COMPANY LIMITED (JP) | 1986-02-19 | — | — | EP | disclosed |
| EP-0165384-A1 | Carbapenem derivatives, their preparation and compositions containing them | SANKYO COMPANY LIMITED (JP) | 1985-12-27 | — | — | EP | disclosed |
| US-4552873-A | BACTERICIDES | SANKYO COMPANY LIMITED (JP) | 1985-11-12 | — | — | US | disclosed |
| EP-0072710-A1 | Carbapenem derivatives, their preparation and compositions containing them | SANKYO COMPANY LIMITED (JP) | 1983-02-23 | — | — | EP | disclosed |
| US-3992453-A | Hydroformylation process | UNIVERSAL OIL PRODUCTS COMPANY (US) | 1976-11-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260085218-A1 | SEALANT RESIN COMPOSITION, AND USE THEREOF | RAD51, RPL24, F10 | ALDH1A1 2089/4885NAAA 2541/4885EPHX1 1430/4885 |
| US-20100197952-A1 | PROCESS FOR PRODUCING DIPHENYL CARBONATE | CA3, DAGLA, CA2 | ALDH1A1 1896/4885NAAA 931/4885EPHX1 2365/4885 |
| US-20120190878-A1 | PROCESS FOR PRODUCING DIPHENYL CARBONATE | CA3, DAGLA, CA2 | ALDH1A1 1896/4885NAAA 931/4885EPHX1 2365/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.